Phoenix Life Sciences International Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PLSI research report →
Companywww.phoenixlife.co
Phoenix Life Sciences International Limited operates as a healthcare solutions company in the United States and internationally. The company focuses on advancing research, integrating programs, and manufacturing of products that target and treat diabetes, pain, and cancers, as well as address psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. It offers oral soft gel capsules, thin film dissolvable strips, transdermal patches, sublingual oral sprays, suppositories, and topical creams.
- CEO
- Willis Victory
- IPO
- 2011
- Employees
- 5
- HQ
- Las Vegas, NV, US
Price Chart
Valuation
- Market Cap
- $365.91K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.07
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -71.46%
- ROIC
- -30.24%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-3,117,000 · -3969.72%
- EPS
- $-89.11 · -3522.36%
- Op Income
- $-3,062,000
- FCF YoY
- -187679.48%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 204.07
- Avg Volume
- 1.15K
Get TickerSpark's AI analysis on PLSI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PLSI Coverage
We haven't published any research on PLSI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PLSI Report →